Calliditas Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of enterprise cloud cybersecurity infrastructure illustrating how Accenture plc and Google Cloud are strengthening cloud security defenses against AI-driven cyber threats and multi-cloud security risks.

How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure

Four-decade-first: Lok Sabha votes down no-confidence motion against Speaker Om Birla

Representative image illustrating an advanced AI system operating software autonomously, reflecting the Macrohard project unveiled by Tesla, Inc. and xAI, which Elon Musk claims could replicate the full operational functions of software companies using agentic artificial intelligence.

Macrohard : The AI project Musk says no other company can do yet, and what that claim actually means

United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF

Calliditas Therapeutics secures TARPEYO FDA approval for IgAN treatment

Read More

2 minute read

Pharma Industry News

Calliditas Therapeutics bags TARPEYO FDA approval for IgAN

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) has announced a landmark FDA approval for TARPEYO (budesonide) delayed…

byPallavi Madhiraju

December 21, 2023

Read More

2 minute read

Pharma Industry News

Calliditas Therapeutics initiates Phase 3 NEFIGARD trial for Nefecon to treat IgA nephropathy

Swedish pharmaceutical company Calliditas Therapeutics has initiated the Phase 3 NEFIGARD trial to evaluate its lead drug candidate,…

bypharmanewsdaily

November 14, 2018

web analytics